Medindia
Medindia LOGIN REGISTER
Advertisement

VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea

Thursday, January 7, 2010 Research News
Advertisement
Qnexa Treatment Results in 69% Reduction in Sleep Apnea Events

CONTACT:  

VIVUS, Inc.

Investor Relations:

The Trout Group

Timothy E. Morris

Brian Korb

Chief Financial Officer

646-378-2923

650-934-5200

Media Relations:

Pure Communications, Inc.

Dan Budwick

973-271-6085

Sponsored Post and Backlink Submission


Latest Press Release on Research News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close